The U.S. Conference on HIV/AIDS (USCHA), takes place annually in … “Beyond Belief.” Presented by drugmaker ViiV Healthcare, it featured five memorable speakers … the 2025 US Conference on HIV/AIDS. With apologies to DaVinci …

… the medicine’s manufacturer, ViiV Healthcare, had yet to share … President’s Emergency Plan for Aids Relief (Pepfar) announced … injections would avert more HIV infections than prevention pills. … country’s tight healthcare budget. HIV prevention pills are …

… supplies of lenacapavir. Are HIV prevention injections cost effective … the cost-effectiveness of HIV injections to the widely … prevention injections will avert more HIV infections than prevention pills. … faster licensing approach than ViiV, he adds Compared to …

… therapy for people with HIV. They enrolled 556 … provides important evidence for HIV practitioners and researchers … 2025, in The Lancet HIV. LIMITATIONS: Dolutegravir and lamivudine … study received funding from ViiV Healthcare, Centro de Investigación Biomédica …

… understanding of patient needs. ViiV Healthcare’s HIV-focused mission translated into strong … HIV/AIDS The report underscores that patient advocacy directly shapes HIV/AIDS … Report and receive your HIV/AIDS advocacy performance dashboard, visit …

… , August 31, marks National Faith HIV/AIDS Awareness Day (#NFHAAD) 2025 … year. Earlier this summer, ViiV Healthcare, an HIV pharmaceutical company, partnered with LGBTQ … “COMmitment to Partnership in Addressing HIV/AIDS in Southern States.”) For …

… & awareness. In HIV, myths continue to persist … The Tackle HIV campaign, founded by Thomas and ViiV Healthcare in … HIV is a campaign led by Gareth Thomas in partnership with ViiV Healthcare … stigma and misunderstanding around HIV. For more information …

… ,” the panel was presented by ViiV Healthcare, an HIV pharmaceutical company. In addition … youth. To learn more about HIV and AIDS, check out the POZ … , read about the National Black HIV/AIDS Awareness Day 2025, which …

… and adolescents with increased HIV acquisition risk who … and shorter-acting injectables like ViiV Healthcare's Apretude (cabotegravir) … the Global Fund to Fight AIDS, Tuberculosis, and Malaria … 100% effective at preventing HIV transmission. Photo by …

… Descovy, and Pfizer Inc. PFE/GSK Plc GSK-backed ViiV Healthcare’s injectable Apretude … criticism from HIV advocates. Mitchell Warren, executive director of the AIDS nonprofit … most insurers continue to cover HIV prevention products without cost barriers …